15th International Podocyte Conference and 2025 ISGD Meeting
June 10 - 13, 2025
Germany
A New Dawn for IgA Nephropathy – Redefining What is Possible with Sparsentan Presented by Travere and ISN
March 11, 2025
Virtual
National Kidney Foundation (NKF) Spring Clinical Meetings 2025
April 10 - 13, 2025
Boston
World Congress of Nephrology (WCN) 2025
February 6 - 9, 2025
India
ASN Update
Exploring the Mechanism of Sparsentan in IgAN: Including a Spotlight on Urinary sCD163, a Key Marker of Inflammation
ASN 2024 Spotlight: New Treatment Targets in IgA Nephropathy
Sparsentan as First-Line Treatment of Incident Patients With IgA Nephropathy (IgAN): Interim Analysis of the SPARTAN Trial
Sparsentan, a Dual Endothelin Type A and Angiotensin II Subtype 1 Receptor Antagonist for the Treatment of Immunoglobulin A Nephropathy: Latest Trial Results, Pharmacokinetic Considerations, and Binding Profile
American Society of Nephrology (ASN) Kidney Week 2024
October 23 - 27, 2024
CA